Laboratory

Moriarty has experience in building a number of laboratories suited for medical research, chemistry, bio tech, and pharmaceutical research and testing. These environments have been constructed under demanding criteria, such as those required to support NIH research, vivariums and bio tech process development.

Page Graphic: Novartis

Novartis

Cambridge, MA
A 450,000 SF lab conversion including significant base building renovations and laboratory fit-up.

Yale School of Medicine Research Support Laboratory Phase II

Yale School of Medicine Research Support Laboratory Phase II

New Haven, CT
Expansion and modification of existing research support laboratory facility.

Page Graphic: Schlumberger

Schlumberger Doll/Draper Labs

Cambridge, MA
A 200,000 SF core / shell renovation / addition including 160,000 SF of Schlumberger chemistry, biology and physics laboratory fit-up.

Alkermes

Alkermes

Cambridge, MA
Office building including micro technology research and development space, including tenant laboratory research building.

Page Graphic: New England Bio Labs

New England Biolabs

Ipswich, MA
Genetic research and production laboratory facility with a stand-alone waste treatment facility.  Exterior curtainwall and copper clad metal panels.  One of the first projects in MA to achieve LEED certification.

Testimonial

We are happy to have had the opportunity to work in partnership with John Moriarty & Associates, Inc. over the past 15 years.John Moriarty and his team are extremely experienced, thoughtful and thorough in their understanding of complex projects.  They understand what it takes to deliver for an owner.  Their team worked seamlessly with our development staff and have always over-delivered on both budget and schedule constraints.From the first meeting to the last, we feel taken care of.  Never once in over 15 years and 2.5 million square feet have we ever had to pull the contract out of the drawer.  Our relationship with John Moriarty & Associates had been a critical piece of our team’s success. We thank them for that.

From: Paul Marcus, Marcus Partners, Inc.